JOURNAL OF COMPARATIVE PATHOLOGY, published by Elsevier Science Ltd, stands as a significant publication within the fields of pathology and forensic medicine, as well as veterinary studies. With an ISSN of 0021-9975 and an E-ISSN of 1532-3129, this journal has been disseminating critical research since 1950, contributing to the advancement of knowledge through its focus on comparative pathology. The journal's reputable standing is underscored by its Q3 classification in Pathology and Forensic Medicine and Q2 in Veterinary (miscellaneous) for 2023, reflecting its vital role in shaping contemporary discourse in these domains. The Scopus ranks further solidify its presence, placing it at the 51st percentile in general veterinary sciences and the 32nd percentile in pathology—a testament to the quality and relevance of the contributions it publishes. Although it operates under a subscription model, the journal remains accessible to researchers and practitioners who aim to deepen their understanding of pathological phenomena across species, enhance diagnostic accuracy, and improve clinical practices. With a steadfast commitment to rigorous peer review and a global readership, the JOURNAL OF COMPARATIVE PATHOLOGY is an essential resource for those engaged in research and professional practice, fostering collaborations and innovations that bridge complementary areas of study.

UROLOGIA INTERNATIONALIS is a prestigious peer-reviewed journal published by KARGER, specializing in the field of urology. Established in 1955, this journal has a long-standing tradition of disseminating high-quality research and clinical studies that contribute to advancements in urological science and practice. With an impact factor reflective of its influential role in the field, UROLOGIA INTERNATIONALIS operates within the Q2 category in Urology, ranking 49th out of 120 journals in its discipline according to Scopus metrics. This makes it a vital resource for researchers, professionals, and students dedicated to understanding and innovating within urological medicine. The journal is based in Switzerland, with its offices located in Basel, and continues to evolve, ensuring that it presents the most relevant and impactful research to its audience.

Head & Neck Pathology is a leading journal dedicated to advancing the study of pathologies affecting the head and neck region, published by Springer. With an ISSN of 1936-055X and E-ISSN of 1936-0568, this journal serves as a vital resource for the dissemination of research in oncology, otorhinolaryngology, and pathology, achieving impressive rankings of Q2 in Oncology and Q1 in both Otorhinolaryngology and Pathology & Forensic Medicine in 2023. Since its inception in 2007, Head & Neck Pathology has continued to provide a platform for innovative research findings, case studies, and reviews, fostering a deeper understanding of head and neck diseases. The journal's commitment to excellence is reflected in its rigorous peer-review process and accessibility through various academic platforms. Researchers, clinicians, and students will find valuable insights and knowledge that can enhance clinical practice and improve patient outcomes in the dynamic field of head and neck pathology.

CLINICAL NEUROPATHOLOGY is a vital scholarly journal published by DUSTRI-VERLAG DR KARL FEISTLE, specializing in the domains of neurology, pathology, and their clinical applications. Established in 1982 and spanning through to its projected completion in 2024, this journal disseminates high-quality research that significantly contributes to the understanding of neurological disorders and their pathological underpinnings. While the journal currently operates under a traditional access model, its commitment to rigorous peer review ensures the publication of impactful findings, strengthening its foothold in the field, as evidenced by its Q3 quartile rankings in several categories, including Medicine (miscellaneous), Neurology, and Pathology and Forensic Medicine. Those engaged in clinical research and practice will find CLINICAL NEUROPATHOLOGY to be an essential resource for the latest advancements, trends, and discussions that shape the future of neurological pathology.

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE is a prominent scientific journal focusing on the fields of neurology and neurosurgery, published by the esteemed Czech Medical Society. Since its inception in 1973, the journal has aimed to disseminate significant research and advancements in clinical neurology and surgery, contributing to the body of knowledge for professionals and researchers in these fields. Operating under a non-open access model, it maintains a dedicated readership interested in valuable insights from the latest studies and clinical practices. The journal is currently classified in the Q4 category in both Neurology (Clinical) and Surgery, reflecting its ongoing efforts to provide a platform for impactful research, despite being ranked in the lower percentiles within Scopus. Based in Prague, Czech Republic, this journal not only serves as a repository of clinical findings but also encourages collaboration and scholarly dialogue among neurologists and neurosurgeons, driving the field towards further innovations in patient care. With coverage extending from 1973 to 2024, it stands as a key resource for those committed to advancing neurological and surgical sciences.

Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.

The Journal of Korean Neurosurgical Society, with its ISSN 2005-3711 and E-ISSN 1598-7876, stands as a paramount resource in the field of neurosurgery, bridging clinical practice and cutting-edge research in both neurology and multidisciplinary neuroscience. Published by the Korean Neurosurgical Society, this open-access journal has been committed to disseminating invaluable knowledge to the global scientific community since its establishment in 1972. Located in Seoul, South Korea, the journal underscores its prominence with impressive quartile rankings—Q3 in Neurology (Clinical), Q3 in Neuroscience (Miscellaneous), and Q2 in Surgery for 2023. Its standing in Scopus rankings further emphasizes its impact, with a ranking of #195/551 in Medicine: Surgery and #235/400 in Medicine: Neurology (Clinical). By fostering a platform for innovative findings and advancements in surgical techniques, the Journal of Korean Neurosurgical Society aims to support professionals, researchers, and students alike in their pursuit of excellence and knowledge in neurosurgery and related fields, ensuring a brighter future for patient care and scientific inquiry.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, published by Oxford University Press Inc, stands as a pivotal resource for advancing research and knowledge in the domains of neuropathology and experimental neurology. Established in 1942, this esteemed journal has expanded its influence, as evidenced by its Q1 rankings in both Neurology (clinical) and Pathology and Forensic Medicine, along with its strong placement in Cellular and Molecular Neuroscience. With an emphasis on innovative research and clinical practices, it caters to a diverse audience, including researchers and clinicians dedicated to understanding neurological disorders through a multidisciplinary lens. While not open access, this journal provides access to cutting-edge studies that are pivotal in shaping the future of medical science and pathology. Researchers benefit from its rigorous peer-review process, ensuring the publication of high-caliber work that meets the evolving demands of the field.

Fetal and Pediatric Pathology, an esteemed journal published by TAYLOR & FRANCIS INC, is dedicated to advancing the field of pediatric and fetal medicine through the dissemination of high-quality research and clinical insights. With an ISSN of 1551-3815 and an E-ISSN of 1551-3823, the journal has been a key resource for researchers and practitioners since its inception in 1983. Based in the United Kingdom, it covers a broad spectrum of topics relevant to Medicine, Pathology and Forensic Medicine, and Pediatrics, Perinatology, and Child Health, consistently reflecting on contemporary challenges faced in these fields. The journal has attained a commendable Q3 ranking within its categories as of 2023, underlining its relevance in the academic community. Though not an open-access publication, the research presented in Fetal and Pediatric Pathology plays a pivotal role in informing practice, guiding future studies, and enhancing the understanding of diseases affecting fetuses and children. Its convergence of research throughout multiple years, continuing until 2024, marks it as a crucial platform for ongoing scientific dialogue and innovation, aimed at fostering better health outcomes for younger populations.

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.